Recent advance in Immunotherapy of Acute Myeloid Leukemia

Nahla AM Hamed
Additional contact information
Nahla AM Hamed: Hematology Department, Alexandria University, Egypt

Cancer Therapy & Oncology International Journal, 2018, vol. 11, issue 5, 31-33

Abstract: Multiple malignancies showed incredible success with immunotherapy treatment. Immunotherapy for AML is now heavily researched being a highly promising strategy, particularly in transplant-ineligible patients and minimal residual disease states despite many challenges in treatment related to heterogeneous antigen expression, cytokine release syndrome and off target toxicities.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555824.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555824.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:11:y:2018:i:5:p:31-33

DOI: 10.19080/CTOIJ.2018.11.555824

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().